US7087649B2ExpiredUtilityA1

Methods for preventing and treating diseases and conditions associated with cellular stress

80
Assignee: EISAI CO LTDPriority: Jun 7, 2001Filed: Jun 7, 2002Granted: Aug 8, 2006
Est. expiryJun 7, 2021(expired)· nominal 20-yr term from priority
A61P 29/00A61P 31/04A61P 1/08A61K 31/121A61P 1/14A61P 1/04A61P 1/00
80
PatentIndex Score
21
Cited by
8
References
8
Claims

Abstract

This invention relates to methods of preventing and treating diseases and conditions associated with cellular stress. The methods involve administration of an effective amount of a compound of the formula:

Claims

exact text as granted — not AI-modified
1. A method of ameliorating one or more symptoms of an alcohol-induced or alcohol-exacerbated injury to, or condition of, the gastrointestinal tract in a person, said method comprising administering to said person an effective amount of a compound of the formula: 
       
         
           
           
               
               
           
         
       
       wherein the injury or condition is selected from the group consisting of hangover, Crohn's disease, and ulcerative colitis. 
     
     
       2. The method of  claim 1 , wherein said injury or condition is hangover. 
     
     
       3. The method of  claim 1 , wherein administration is carried out either: (i) within two hours prior to drinking an alcoholic beverage; (ii) during the period of drinking alcoholic beverages; (iii) within one hour after drinking the last in a series of alcoholic beverages; (iv) within fourteen hours after drinking the last in a series of alcoholic beverages; or (v) two or more of (i)–(iv). 
     
     
       4. The method of  claim 1 , wherein the total amount of said compound administered over a fourteen-hour period is 10–1,000 mg. 
     
     
       5. The method of  claim 4 , wherein the total amount of said compound administered in said period is 50–500 mg. 
     
     
       6. The method of  claim 5 , wherein the total amount of said compound administered is 100–300 mg. 
     
     
       7. The method of  claim 1 , wherein the injury or condition is Crohn's disease. 
     
     
       8. The method of  claim 1 , wherein the injury or condition is ulcerative colitis.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.